Harvest Group Wealth Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Harvest Group Wealth Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-91	Closed	-$3K	–	894
2020 Q2	$3K	Hold	91	–	–	﹤0.01%	289
2020 Q1	$2K	Sell	91 -79	-46%	-$2.2K	﹤0.01%	336
2019 Q4	$3K	Buy	170 +46	+37%	+$736	﹤0.01%	560
2019 Q3	$2K	Sell	124 -2	-2%	-$24	﹤0.01%	801
2019 Q2	$1K	Hold	126	–	–	﹤0.01%	871
2019 Q1	$2K	Buy	+126	New	+$1.61K	﹤0.01%	709

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Harvest Group Wealth Management's MNTA Position: Q3 2020 in Review

Harvest Group Wealth Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 91 shares — an estimated $3K sold.

Harvest Group Wealth Management first reported a position in MNTA in Q1 2019 and held it in 6 quarters. The position peaked at $3K in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

Harvest Group Wealth Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Harvest Group Wealth Management sold 91 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $3K.
Harvest Group Wealth Management first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2019 and held it in 6 quarters.
Harvest Group Wealth Management's Momenta Pharmaceuticals, Inc. position peaked at $3K in Q2 2020.
211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Harvest Group Wealth Management's 13F filing for Q3 2020, filed 9 Nov 2020.